In addition to this and other JAK2-activating mutations, mutations in genes encoding epigenetic modulators such as TET2, ASXL1, EZH2 and IDH1/2 have been described in MPN [8–10]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.